According to OPKO Health 's latest financial reports and stock price the company's current number of shares outstanding is 751,506,257. At the end of 2023 the company had 751,506,257 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 0.75 B | 0.18% |
2022 | 0.75 B | 15.1% |
2021 | 0.65 B | 1.75% |
2020 | 0.64 B | 2.91% |
2019 | 0.62 B | 6.34% |
2018 | 0.58 B | 4% |
2017 | 0.56 B | -17.83% |
2016 | 0.68 B | 25.67% |
2015 | 0.54 B | 23.41% |
2014 | 0.44 B | 22.47% |
2013 | 0.36 B | 20.98% |
2012 | 0.29 B | 4.38% |
2011 | 0.28 B | 11.88% |
2010 | 0.25 B | 0.9% |
2009 | 0.25 B | 34.84% |
2008 | 0.18 B | 15.25% |
2007 | 0.16 B | 214.69% |
2006 | 51.73 M | 218.02% |
2005 | 16.26 M | 0.24% |
2004 | 16.22 M | 3.48% |
2003 | 15.68 M | 0.06% |
2002 | 15.67 M | -3.1% |
2001 | 16.17 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | 2,407,200,000 | 220.32% | ๐บ๐ธ USA |
Abbott Laboratories ABT | 1,734,076,358 | 130.75% | ๐บ๐ธ USA |
Regeneron Pharmaceuticals REGN | 106,300,000 | -85.86% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | 2,057,000,000 | 173.72% | ๐บ๐ธ USA |
LabCorp LH | 84,900,000 | -88.70% | ๐บ๐ธ USA |
Alnylam Pharmaceuticals
ALNY | 125,220,000 | -83.34% | ๐บ๐ธ USA |
Teva Pharmaceutical Industries TEVA | 1,121,000,000 | 49.17% | ๐ฎ๐ฑ Israel |
Ardelyx ARDX | 222,782,229 | -70.36% | ๐บ๐ธ USA |